CRISPR Therapeutics AG Watch

from 8-K 36 pages Articles of Incorporation or Bylaws

from 8-K 39 pages Articles of Association Statuten of Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Mit Sitz in Zug Zug (Translation; in Case of Controversy the German Text Shall Prevail) I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Art. 1 Firma, Sitz Und Dauer Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug. Art. 2 Purpose Art. 2 Zweck the Purpose of the Company Is the Research and Development in the Field of Pharmaceutical Products, Including Biological and Biotechnological Products, as Well as the Production and Commercialisation of Such Products. Die Gesellschaft Bezweckt Die Forschung Und Entwicklung Auf Dem Gebiet Von Pharmazeutischen Produkten, Einschliesslich Biologischen Und Biotechnologischen Produkten, Sowie Die Herstellung Und Kommerzialisierung Derartiger Produkte. the Company May Purchase, Hold and Sell Patents, Copy Rights, Trade Marks and Other Intellectual Property Rights as Well as Licenses of Any Kind. Die Gesellschaft Kann Patente, Urheberrechte, Marken Und Andere Immaterialgüterrechte Sowie Lizenzen Jeder Art Erwerben, Halten Und Veräussern

from 8-K 53 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug. 2

from 8-K 39 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug

from 10-K 40 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug. 2

from 8-K 40 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I.CORPORATE Name, Principal Office, Duration and Purpose of the Company I.FIRMA, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Art. 1firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug. 2

from 10-K 39 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug. 2

from 8-K 41 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug. Art. 2 Purpose Art. 2 Zweck the Purpose of the Company Is the Research and Development in the Field of Pharmaceutical Products, Including Biological and Biotechnological Products, as Well as the Production and Commercialisation of Such Products. the Company May Purchase, Hold and Sell Patents, Copy Rights, Trade Marks and Other Intellectual Property Rights as Well as Licenses of Any Kind. Die Gesellschaft Bezweckt Die Forschung Und Entwicklung Auf Dem Gebiet Von Pharmazeutischen Produkten, Einschliesslich Biologischen Und Biotechnologischen Produkten, Sowie Die Herstellung Und Kommerzialisierung Derartiger Produkte. Die Gesellschaft Kann Patente, Urheberrechte, Marken Und Andere Immaterialgüterrechte Sowie Lizenzen Jeder Art Erwerben, Halten Und Veräussern

from 10-Q 37 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug, the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Akti-Engesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug

from 8-K 40 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Zug (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Zug I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Zug. the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Zug. Art. 2 Purpose the Purpose of the Company Is the Research and Development in the Field of Pharmaceutical Products, Including Biological and Biotechnological Products, as Well as the Production and Commercialisation of Such Products. the Company May Purchase, Hold and Sell Patents, Copy Rights, Trade Marks and Other Intellectual Property Rights as Well as Licenses of Any Kind. Art. 2 Zweck Die Gesellschaft Bezweckt Die Forschung Und Entwicklung Auf Dem Gebiet Von Pharmazeutischen Produkten, Einschliesslich Biologischen Und Biotechnologischen Produkten, Sowie Die Herstellung Und Kommerzialisierung Derartiger Produkte. Die Gesellschaft Kann Patente, Urheberrechte, Marken Und Andere Immaterialgüterrechte Sowie Lizenzen Jeder Art Erwerben, Halten Und Veräussern

from 8-K 41 pages Articles of Association of CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) With Registered Office in Basel (Translation; in Case of Controversy the German Text Shall Prevail) Statuten Der CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Mit Sitz in Basel I. Corporate Name, Principal Office, Duration and Purpose of the Company I. Firma, Sitz, Dauer Und Zweck Der Gesellschaft Art. 1 Corporate Name, Principal Office and Duration Under the Name CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) There Exists a Company Which Is Subject to the Provisions of Art. 620 Et Seq. of the Swiss Code of Obligations (Co) With Registered Office in Basel. the Duration of the Company Is Unlimited. Art. 1 Firma, Sitz Und Dauer Unter Der Firma CRISPR Therapeutics AG (Crispr Therapeutics SA) (Crispr Therapeutics Ltd) Besteht Für Unbeschränkte Dauer Eine Aktiengesellschaft Gemäss Art. 620 Ff. or Mit Sitz in Basel. Art. 2 Purpose the Purpose of the Company Is the Research and Development in the Field of Pharmaceutical Products, Including Biological and Biotechnological Products, as Well as the Production and Commercialisation of Such Products. the Company May Purchase, Hold and Sell Patents, Copy Rights, Trade Marks and Other Intellectual Property Rights as Well as Licenses of Any Kind. Art. 2 Zweck Die Gesellschaft Bezweckt Die Forschung Und Entwicklung Auf Dem Gebiet Von Pharmazeutischen Produkten, Einschliesslich Biologischen Und Biotechnologischen Produkten, Sowie Die Herstellung Und Kommerzialisierung Derartiger Produkte. Die Gesellschaft Kann Patente, Urheberrechte, Marken Und Andere Immaterialgüterrechte Sowie Lizenzen Jeder Art Erwerben, Halten Und Veräussern

from S-1 23 pages Statuten / Articles of Incorporation Der / of CRISPR Therapeutics AG [Crispr Therapeutics SA; Crispr Therapeutics Ltd]

from DRS/A 23 pages Statuten / Articles of Incorporation Der / of CRISPR Therapeutics AG [Crispr Therapeutics SA; Crispr Therapeutics Ltd]